CSIMarket Company Name, Ticker, Suppliers, else..
 
Predictive Oncology Inc   (NASDAQ: POAI)
Other Ticker:  
 
 
Price: $1.0600 $-0.03 -2.752%
Day's High: $1.1353 Week Perf: 23.26 %
Day's Low: $ 1.00 30 Day Perf: -33.75 %
Volume (M): 99 52 Wk High: $ 3.06
Volume (M$): $ 105 52 Wk Avg: $1.11
Open: $1.10 52 Wk Low: $0.55



 Market Capitalization (Millions $) 6
 Shares Outstanding (Millions) 5
 Employees 23
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -13
 Cash Flow (TTM) (Millions $) -8
 Capital Exp. (TTM) (Millions $) 0

Predictive Oncology Inc
Predictive Oncology Inc is a company that focuses on using artificial intelligence (AI) and data analytics to provide personalized treatment options for cancer patients. They analyze large amounts of genomic and clinical data to develop models that help in predicting the most effective treatment methods for different types of cancer. Their aim is to improve patient outcomes by delivering targeted therapies that are tailored to individual patients based on the specific genetic mutations present in their tumors.


   Company Address: 91 43rd Street, Suite 110 Pittsburgh 15201 PA
   Company Phone Number: 432-1500   Stock Exchange / Ticker: NASDAQ POAI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
WGS      % 
EXAS      % 
GH        13.35% 
MYGN        13.35% 
• View Complete Report
   



Merger and Acquisition

Predictive Oncology Enters Strategic Alliance with STREAMWAY Systems to Enhance Innovative Cancer Treatment Solutions,

Published Thu, Mar 20 2025 11:00 AM UTC

Predictive Oncology and STREAMWAY Systems: A Partnership Forging New Heights in Cancer Care InnovationOn March 3, 2025, Predictive Oncology Inc. (NASDAQ: POAI) took a significant step toward revolutionizing cancer care by announcing its first financing tranche involving the sale of its Skyline Medical assets to DeRoyal Industries. This deal positions STREAMWAY Systems, renow...
Merger and Acquisition

Predictive Oncologys First Financing Tranche: A Leap Towards Merging AI with Cancer Care Innovations,

Published Mon, Mar 3 2025 2:01 PM UTC

Predictive Oncology Secures Funding to Pave the Way for AI-Driven Cancer SolutionsOn February 19, 2025, Predictive Oncology, a trailblazer in cancer treatment innovations, marked a significant milestone in its growth trajectory with the announcement of a successful strategic direct stock offering and its formal initiation of pioneering partnerships in artificial intelligenc...
Shares

Predictive Oncology Enhances Cancer Treatment Innovations with Strategic Direct Stock Offering and Pioneering AI Partnerships,

Published Wed, Feb 19 2025 1:00 PM UTC

In a strategic move to bolster its cutting-edge research and development initiatives, Predictive Oncology Inc. (NASDAQ: POAI) has announced an at-the-market registered direct offering of 363,336 shares of common stock, priced at $1.50 per share. This move aligns with the company s commitment to advancing its prowess in AI-driven drug discovery and biologics, positioning itse...
Merger and Acquisition

Predictive Oncology Inc. Unveils Promising Synergies in Cancer Treatment with AI Partnership

Published Mon, Jan 6 2025 2:10 PM UTC

Breaking News: Predictive Oncology Inc. Advances Cancer Treatment by Leveraging AI and Machine Learning SynergiesIn a groundbreaking development on August 27, 2024, Predictive Oncology Inc. (NASDAQ: POAI) announced a significant collaboration aimed at revolutionizing cancer therapy and vaccine development. The company, renowned for its innovative use of artificial intelligen...
Clinical Study

Harnessing Biobanks and AI for Revolutionary Advances in Oncology and Vaccine Development

Published Tue, Aug 27 2024 12:00 PM UTC

Abstract Recent advances in predictive oncology highlight the significant interplay between biobanks, artificial intelligence (AI), and pharmaceutical development. Predictive Oncology Inc. has reported substantial findings on the viability and stability of its proprietary biobank for primary tumor specimens, which enhances the predictability of patient outcomes in drug dis...






Predictive Oncology Inc's Segments
Pittsburgh    1.13 % of total Revenue
Eagan    98.87 % of total Revenue





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com